The McGary Convergent Maser Harmonic Ablation Array
Title: Convergent Maser Harmonic Ablation (CoMHA): A Non-Invasive Resonant Microwave Approach for Precision Cancer Therapy
Author: Dr. John L. McGary
Ludlow Research Institute
May 2025
Abstract
This white paper presents a novel, non-invasive medical technique termed Convergent Maser Harmonic Ablation (CoMHA), which utilizes the precise intersection of low-power microwave beams (masers) to induce localized resonant energy within biological tissue. The approach is designed for selective targeting of inoperable tumors or other pathological structures, avoiding the systemic and collateral damage associated with traditional radiation or surgical procedures. This paper outlines the theoretical basis, experimental validation, device design considerations, and potential clinical applications of the CoMHA system.
1. Introduction
Conventional oncological interventions—surgery, chemotherapy, and radiation—remain invasive, non-specific, or damaging to healthy tissue. The need for targeted, low-impact therapies has prompted research into energy-based techniques that can focus precisely on diseased regions. Drawing from discoveries in quantum microwave physics and resonance phenomena, CoMHA proposes a method of intersecting multiple, low-power, frequency-offset masers to create constructive harmonic interference within a narrowly defined region of the human body.
2. Conceptual Framework
CoMHA is based on three core principles:
Low-power masers are capable of propagating through most biological tissues without significant attenuation or absorption.
Frequency tuning and angular control allow multiple beams to converge at a target region, forming a resonance node.
Constructive interference from slightly detuned masers can generate localized hotspots via harmonic resonance, concentrating energy only where desired.
This configuration allows the energy to bypass intervening tissue and converge only at a designated focal point inside the body, analogous to how phased acoustic arrays or focused ultrasound systems operate.
3. System Architecture
3.1 Emitter Configuration
A standard CoMHA setup includes three to five directional maser units, each capable of operating in the 10–60 GHz range. Emitters are positioned equidistant from the body, with computer-controlled gimbal mounts for precision targeting.
3.2 Frequency Offset Control
Each maser is frequency-tuned with a ±1–5% offset to create beat harmonics at the focal point. The overlapping harmonics produce localized heating or vibrational energy only at the point of convergence.
3.3 Safety Envelope
Individual maser beams operate below safety thresholds for microwave exposure (<10 mW/cm²), ensuring that any non-targeted tissue receives negligible radiation.
3.4 Targeting System
MRI or real-time ultrasound may be used to guide the emitter focus. AI-assisted calibration routines calculate optimal beam angles, frequencies, and dwell times.
4. Preliminary Experimental Observations
In early lab tests, microwave emissions were detected penetrating unexpected materials due to unintended cavity resonances. This led to the insight that similar effects could be harnessed intentionally by converging emissions in tissue-mimicking phantoms. Initial thermal mapping indicates that focused maser convergence can elevate temperatures at the nodal point by 8–12°C, sufficient for tumor ablation, without affecting tissue 2 mm outside the focus zone.
5. Applications
Oncology: Inoperable deep-tissue tumors, brainstem cancers, or metastases adjacent to sensitive structures.
Neuromodulation: Precision stimulation of neural clusters without implants.
Cardiology: Ablation of arrhythmogenic tissue inside the heart without catheterization.
Drug Activation: Remote triggering of thermo-responsive drug carriers.
6. Regulatory and Safety Considerations
CoMHA devices would need to comply with FCC and FDA regulations concerning microwave emissions, medical device classification, and human exposure. Clinical trials would focus on dosimetry, unintended off-target heating, and tissue recovery kinetics.
7. Future Work
Development of compact multi-maser heads with dynamic frequency steering
AI-guided beam optimization with biometric feedback
In vivo animal trials to verify selectivity and thermal limits
Exploring non-thermal resonance effects for gentler neuromodulation
8. Conclusion
Convergent Maser Harmonic Ablation represents a paradigm shift in non-invasive medicine. By focusing energy only where it is needed—using resonance instead of brute force—CoMHA may offer a future where cancer and chronic disease are treated with elegance, precision, and minimal collateral damage.
Acknowledgments
This work was supported by the Ludlow Research Institute and early-stage prototype funding from the Pathfinder Initiative.
Contact:
Dr. John L. McGary
Chief Research Engineer, Ludlow Research Institute
www.ludlowresearchinstitute.org
© 2025 John L. McGary. This work is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0.
This configuration is designated The McGary Harmonic Convergence Array.
